Page reviewed by: Dr. Cara O'Neill, FAAP Page last updated: July 29, 2022 For web accessibility options: Click/tap the floating blue icon on the right. The ABO-102 Gene Therapy uses a self-complementary adeno-associated virus serotype 9 carrying the human SGSH gene...
Clinical Trial
LYS-SAF302 Gene Therapy | Type IIIA | Phase II-III | Lysogene
Page reviewed by: Dr. Cara O'Neill, FAAP Page last updated: November 21, 2022 For web accessibility options: Click/tap the floating blue icon on the right. Update: Nov. 21, 2022 Lysogene recently issued a press released regarding their Type A gene therapy study. In...